Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	476	352	189	320	198	314
Market Cap Growth	89.47%	86.79%	-41.07%	61.60%	-36.85%	25.86%
Enterprise Value	443	347	181	303	169	271
Last Close Price	18.20	16.40	8.78	14.90	9.22	14.60
PE Ratio	-	-	-	-	85.08	-
PS Ratio	44.60	41.05	10.93	9.02	6.08	18.25
PB Ratio	4.74	3.76	2.17	3.43	2.10	3.40
P/TBV Ratio	18.29	3.76	2.17	3.43	2.10	3.40
P/FCF Ratio	-	-	-	424.69	-	-
P/OCF Ratio	-	-	-	361.41	-	-
EV/Sales Ratio	41.52	40.37	10.50	8.54	5.20	15.75
EV/EBITDA Ratio	-	-	-	-	71.03	-
EV/EBIT Ratio	-	-	-	-	72.74	-
EV/FCF Ratio	-24.72	-	-	402.14	-	-
Debt / Equity Ratio	-	0.04	0.02	-	-	-
Net Debt / Equity Ratio	-0.33	-0.18	-0.18	-0.18	-0.28	-0.45
Net Debt / EBITDA Ratio	2.33	1.14	1.16	8.09	-10.99	6.05
Net Debt / FCF Ratio	1.84	0.94	1.81	-22.56	3.97	8.37
Asset Turnover	0.10	0.09	0.18	0.35	0.32	0.22
Quick Ratio	6.13	4.74	2.59	3.28	4.82	4.71
Current Ratio	6.41	4.98	2.68	3.51	5.00	4.75
Return on Equity (ROE)	-15.35%	-16.29%	-25.74%	-1.93%	2.49%	-9.60%
Return on Assets (ROA)	-8.65%	-9.56%	-8.72%	-1.36%	1.43%	-5.40%
Return on Capital Employed (ROCE)	-13.00%	-15.80%	-15.60%	-2.40%	2.50%	-7.50%
Earnings Yield	-2.97%	-4.17%	-12.29%	-0.56%	1.18%	-2.21%
FCF Yield	-3.77%	-5.03%	-4.58%	0.24%	-3.33%	-1.59%
Buyback Yield / Dilution	-10.88%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.